|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.86 CNY | -1.03% |
|
-19.42% | -61.40% |
Kunming Longjin Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 86.62 million compared to CNY 122.97 million a year ago. Net loss was CNY 70.94 million compared to CNY 56.12 million a year ago.
Basic loss per share from continuing operations was CNY 0.1771 compared to CNY 0.1401 a year ago. Diluted loss per share from continuing operations was CNY 0.1771 compared to CNY 0.1401 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -61.40% | 214M | |
| +21.56% | 44.15B | |
| +23.03% | 23.02B | |
| +20.62% | 15.33B | |
| +12.41% | 13.74B | |
| +50.15% | 12.16B | |
| -10.02% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.88% | 5.66B |
KUNMING LONGJIN PHARMACEUTICAL CO., LTD. 
